South Australian Venture Capital Fund

The South Australian Venture Capital Fund (SAVCF) is a A$50 million government-backed co-investment vehicle established in 2017 by the South Australian Government Financing Authority (SAFA) to back innovative early-stage companies headquartered in South Australia. The fund is managed by Artesian Venture Partners, Australia's largest and most active early-stage VC, which runs SAVCF out of its Adelaide office as part of a broader Asia-Pacific platform with additional offices in Sydney, Melbourne, Singapore, and Shanghai. SAVCF only backs companies that have demonstrated a market, commenced revenue or customer validation, and can scale capital-efficiently into national and global markets. Deployment strategy targets 10 to 20 pre-Series A investments at A$1 million to A$2 million per deal, plus 5 to 12 Series A investments at roughly A$2.5 million, always matched with at least 50% co-investment from other VCs, angels, or strategics. Typical check sizes run $1 million to $2.5 million. The portfolio spans biotech, deep tech, space and IoT, and SaaS, and includes BiomeBank (gut microbiome clinical-stage biotech), Ferronova (cancer diagnostics), Fivecast (OSINT and security analytics), Fleet Space Technologies (low-power satellite IoT), Myriota (satellite IoT), Lumary (healthcare SaaS processing over A$2.5 billion of NDIS services), Kid Sense (paediatric therapy services), Kindship (disability-parent social network), Pearler.AI (tender and grant response AI), Seonix Bio (genetic glaucoma risk), and Val.AI (home energy efficiency). The SAVCF structure reflects a deliberate policy objective: to develop South Australia's innovation ecosystem by ensuring promising local companies attract the co-investment and mentorship needed to scale beyond the state's borders, with Artesian providing the institutional investment infrastructure.